This website is intended for healthcare professionals only

Trending Topic

Close up of doctor holding dermatoscope while examining skin of patient at dermatology clinic
12 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked
Gabriela Franco Katz, Beatriz Mendes Awni Cidale, Ana Zélia Leal Pereira

This article examines current evidence supporting the use of neoadjuvant immunotherapy in patients with resectable macroscopic stage III melanoma and critically discusses the selection of appropriate adjuvant therapy following surgery. It is written in the context of emerging evidence from recent neoadjuvant trials, both in melanoma and across multiple tumor types, suggesting that pathologic response […]

Trauma-related Coagulopathy—Current Concepts

Paul T Engels, J Damian Paton-Gay, Sandy L Widder
< 1 min
Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Download as PDF
Published Online: Jun 25th 2012 Oncology & Hematology Review (US), 2012;8(2):123-8 DOI: https://doi.org/10.17925/OHR.2012.08.2.123
Select a Section…
1

Article

Abstract

Background: Hemorrhage continues to be a major cause of early death in trauma patients. Our understanding of the development of coagulopathy and its importance has evolved significantly over the last decade. In this article, we describe the current understanding of coagulopathy in the setting of trauma including its mechanisms, diagnosis, consequences, and treatment strategies.
Methods: Review of selected articles from MEDLINE.
Results: The occurrence of coagulopathy is common in trauma patients and is multifactorial, with increasing evidence indicating an endogenous mechanism unrelated to the complications of medical treatment. The use of novel coagulation assessment techniques and evolution in blood product treatment strategies is generating a new era of targeted management. Conclusions: Coagulopathy in trauma is common, but newer techniques in diagnosis as well as novel methods to provide targeted treatment offer encouraging results in decreasing the mortality rate from exsanguination after injury.

To view the full article in PDF or eBook formats, please click on the icons above.

2

Further Resources

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Download as PDF
Close Popup